NGF and Parkinson disease: This compound, along with the nerve growth factor (NGF) and plasmid DNA (pDNA), was conjugated with chitosan poly(ethyleneglycol)-polylactic acid (PEG-PLA) NPs (160 nm with positive charge) for PD therapy (Figure 5) [85].